skip to primary navigationskip to content
 

X01 and beyond – fortune favours the prepared mind

Hear how Professor Jim Huntington (founder X01 Ltd) worked with Cambridge Enterprise to form spin out X01 and later ApcinteX and Z Factor - talk followed by a Q&A.
When Jun 08, 2017
from 06:00 PM to 08:00 PM
Add event to calendar vCal
iCal

On Thursday 8th June, in light of their 10th anniversary celebrations, Cambridge Enterprise will be holding the first in a series of Roadshow events showcasing some of the most prominent research that has spun out of the university.

These events are open to academics and postdocs alike from all departments.

X01 and beyond – fortune favours the prepared mind: a talk by Professor Jim Huntington followed by Q&A

X01 developed ichorcumab, a recombinant human antibody that prevents thrombosis without promoting bleeding.

The potential is vast: preventing blood clots without causing excessive bleeding could avert millions of deaths from heart attack and stroke every year.

Outline for the evening:

  • 6-6:20pm (Arrival, networking and refreshments)
  • 6:20-7:15pm (talk/presentation with Professor Jim Huntington)
  • 7:15-7:30pm (Q&A)
  • 7:30-8pm (Networking & refreshments).

This event is free to attend but please register here.

OPdA Tweets

Upcoming events

CEGX: The spinout that’s measuring the epigenome to improve human health

Sep 12, 2017

Pfizer Lecture Theatre, Department of Chemistry, Lensfield Road

Pitching Training Event

Sep 15, 2017

Seminar Room B, 17 Mill Lane

Upcoming events

RSS Feed Latest news

Grants available through the Returning Carers Scheme - apply by 29 September

Aug 16, 2017

The Returning Carers Scheme provides funds to support career development following a career break or a period of leave for caring responsibilities.

Opportunity to apply for up to £30,000 funding from the EPSRC: apply by 16 August

Aug 08, 2017

Postdocs are invited to apply via the OPdA for funding for activities which fall under the remit of the EPSRC and the Global Challenges Research Fund.

View all news